Peter Attia· MD
so you are creating a scenario where that's putting a lot of persistent metabolic stress on the tumor cells and then you come in here with different modalities that have overlapping but independent mechanisms at producing oxidative stress so hyperbaric oxygen IV vitamin C and then cancer specific glycolytic inhibitors to deoxy glucose 3 bromo pyruvate and low nit amine